NCT04522297View on ClinicalTrials.gov

Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

April 15, 2018

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions
Hepato-Renal Syndrome
Interventions
DRUG

Midodrine/Octreotide

oral midodrine plus octreotide as subcutaneous injection

DRUG

Nor-epinephrine

Intravenous infusion norepinephrine

Trial Locations (1)

Unknown

The National Hepatology and Tropical Research medicine institute, Cairo

All Listed Sponsors
lead

National Hepatology & Tropical Medicine Research Institute

OTHER_GOV

NCT04522297 - Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome | Biotech Hunter | Biotech Hunter